Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II SubstudyDepartment of Cardiology, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
Division of Cardiology, University of California-San Diego, San Diego, California, USA.
Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
Clinic of Cardiology, St. Olavs University Hospital, Trondheim, Norway.
Department of Cardiology, Odense University Hospital, Odense, Denmark.
Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Cardiology, Nordland Hospital Trust, Bodø, Norway.
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Medical Sciences and Cardiology, Uppsala University and Uppsala Clinical Research Center, Uppsala, Sweden.
Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.
Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.
NewYork-Presbyterian Hospital and Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Show others and affiliations
2025 (English)In: Journal of the American College of Cardiology, ISSN 0735-1097, E-ISSN 1558-3597, Vol. 85, no 21, p. 2011-2024Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Although lipoprotein(a) (Lp[a]) has been associated with acute myocardial infarction (MI), the relationship between Lp(a) and the presence of high-risk "vulnerable" coronary plaques has not been studied. OBJECTIVES: The aim of this study was to investigate whether specific lipoproteins are associated with pancoronary plaque volume and lipid deposition vs the development of non-flow-limiting high-risk vulnerable plaques.
METHODS: In PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II, 3-vessel coronary artery imaging was performed with a combined near-infrared spectroscopy and intravascular ultrasound catheter after treatment of all flow-limiting lesions in patients with recent MI. The relationships of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (HDL-C), HDL-C, Lp(a), and triglycerides to pancoronary plaque volume, pancoronary lipid core burden index (LCBI), and the presence of focal vulnerable plaques (plaque burden ≥70% and maximum LCBI over any 4-mm segment ≥324.7) were assessed in 865 patients.
RESULTS: By multivariable analysis, TC, LDL-C, and non-HDL-C (but not Lp[a]) were associated with pancoronary plaque volume and pancoronary LCBI (P < 0.01 for all), but not with the presence of vulnerable plaque. Conversely, Lp(a) (but not TC, LDL-C, or non-HDL-C) was associated with the presence of focal vulnerable plaques (P = 0.01).
CONCLUSIONS: In PROSPECT II, elevated TC, LDL-C, and non-HDL-C were strongly associated with pancoronary atherosclerosis and lipid deposition, whereas elevated Lp(a) was strongly associated with the presence of focal vulnerable plaques. These findings may explain the association between high Lp(a) levels and future MI and suggest a unique role for Lp(a) role in atherosclerosis progression and plaque vulnerability. (PROSPECT II & PROSPECT ABSORB-An Integrated Natural History Study and Randomized Trial; NCT02171065).
Place, publisher, year, edition, pages
Elsevier, 2025. Vol. 85, no 21, p. 2011-2024
Keywords [en]
LDL, lipoprotein(a), myocardial infarction, vulnerable plaque
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:oru:diva-121530DOI: 10.1016/j.jacc.2025.04.013ISI: 001503775600003PubMedID: 40436465Scopus ID: 2-s2.0-105005173416OAI: oai:DiVA.org:oru-121530DiVA, id: diva2:1969969
Funder
NIH (National Institutes of Health), R 01 HL1591 562025-06-162025-06-162025-06-17Bibliographically approved